We have compared the efficacy of ketorolac 30 mg i.v. followed by infusion at a rate of 90 mg/15.5 h, with that of diclofenac 75 mg followed by infusion of 75 mg/15.5 h or ketoprofen 100 mg followed by infusion of 100 mg/15.5 h, on postoperative pain in 85 patients after hip replacement surgery under spinal anaesthesia in a prospective, double-blind, randomized study. Supplementary analgesia was administered during the 16-h postoperative period with bolus doses of fentanyl delivered by a patientcontrolled analgesia system. Mean total consumption of PCA-administered fentanyl was 890 (SD 400) g in the ketorolac group, 920 (550) g in the diclofenac group and 850 (350) g in the ketoprofen group (ns). Median VAS scores were low over the entire study in each group and there was no significant difference between groups.
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Summary
We have compared the efficacy of ketorolac 30 mg i.v. followed by infusion at a rate of 90 mg/15.5 h, with that of diclofenac 75 mg followed by infusion of 75 mg/15.5 h or ketoprofen 100 mg followed by infusion of 100 mg/15.5 h, on postoperative pain in 85 patients after hip replacement surgery under spinal anaesthesia in a prospective, double-blind, randomized study. Supplementary analgesia was administered during the 16-h postoperative period with bolus doses of fentanyl delivered by a patientcontrolled analgesia system. Mean total consumption of PCA-administered fentanyl was 890 (SD 400) g in the ketorolac group, 920 (550) g in the diclofenac group and 850 (350) g in the ketoprofen group (ns). Median VAS scores were low over the entire study in each group and there was no significant difference between groups.
No serious adverse events were recorded. (Br. J. Anaesth. 1998; 81: 369-372). Keywords: analgesia, patient-controlled; non-steroidal anti-inflammatory drugs; analgesics non-opioid, diclofenac; analgesics non-opioid, ketoprofen; analgesics non-opioid, ketorolac; pain, postoperative Non-steroidal anti-inflammatory drugs (NSAID) have become popular for pain relief after orthopaedic surgery and their efficacy has been demonstrated in comparison with placebo.
1-3 NSAID reduce the biosynthesis of prostaglandins by inhibition of the enzyme cyclo-oxygenase (COX). 4 This enzyme exists in two different isoforms (COX-1 and COX-2) and NSAID may differ in their inhibition of both COX-I and COX-2 isoenzymes. 5 Ketorolac inhibits both cyclo-oxygenase and lipooxygenase enzymes thereby preventing the synthesis of both prostaglandins and leukotrienes, 6 and may also release endogenous opioids. 7 These properties of ketorolac may make it more potent than other NSAID. For example, ketorolac 30 mg i.m. has been shown to be as effective as morphine 12 mg i.m. or meperidine 100 mg i.m. for severe pain after major surgery. 8 Although there are many studies comparing NSAID with placebo and opioids, there are few comparisons between NSAID after major surgery. The analgesic efficacy of ketorolac was greater than that of diclofenac after arthroscopy of the knee joint. 9 Niemi, Tuominen and Rosenberg have shown that pain after maxillofacial surgery was reduced more effectively by parenterally administered diclofenac than by parenteral ketoprofen. 10 We investigated if ketorolac offers any advantage over diclofenac or ketoprofen in terms of efficacy of pain relief after hip replacement.
Patients and methods
The study was conducted in accordance with the declaration of Helsinki. After obtaining approval from the Ethics Committee of Kuopio University Hospital and Lappi Central Hospital, and informed written consent, we studied 85 ASA I-III patients, aged 45-81 yr, undergoing total hip replacement surgery, in a double-blind, randomized, comparative study. Patients with hypersensitivity to anti-inflammatory drugs, asthma, clinical hepatic or renal failure, bleeding or coagulation disorders, gastrointestinal ulceration or dyspepsia were excluded. The use of a visual analogue scale (VAS) was explained to the patients during the preoperative visit.
Patients received diazepam 10-15 mg orally as premedication, 40-60 min before the start of spinalanaesthesia. Isobaric 0.5% bupivacaine 15-20 mg was administered spinally at the L2-3 or L3-4 interspace. No NSAID were given during operation.
The study began after operation in the recovery room (Kuopio) or in the intensive care unit (Rovaniemi) when spinal anaesthesia had worn off at the operation site. This was indicated by pinprick response: the patient was able to detect a sharp pinprick (22-gauge needle) at the operation site. Patients were allocated randomly to receive, in a double-blind manner, diclofenac 75 mg, ketoprofen 100 mg or ketorolac 30 mg as an i.v. loading dose for 30 min, followed by infusion of diclofenac 75 mg, ketoprofen 100 mg or ketorolac 90 mg over 15.5 h. A 16-h period was chosen because we were unable to keep the patients in the recovery room or in the intensive care unit for a longer time. A nurse not involved in the study prepared all drugs according to the randomization, in the form of sealed envelopes.
Patients were given access to a patient-controlled analgesia pump (PCA) (Graseby PCAS, Medical Ltd, Watford, Herts, UK) which was programmed to deliver on demand fentanyl 50 g i.v.: infusion time was 5 min, lock-out time was 5 min and maximum dose was 300 g h
91
. Patients were instructed to administer fentanyl whenever they required pain relief, and all successful and unsuccessful demands were recorded.
Pain intensity at rest was assessed using a 10-cm linear VAS (0:no pain, 10:worst pain imaginable). Patients undergoing total hip replacement are not usually mobile during the first 24 h, so pain intensity was assessed only at rest. The first postoperative pain score was obtained before the i.v. loading dose, the next score at the end of the loading dose and then at 3, 6, 10, 13 and 16 h after the beginning of the study. Pain at the infusion site during infusion of the loading dose was noted.
Sedation was recorded at the same intervals by nurses (0:completely alert, 1:dozes now and then, but answers immediately, 2:asleep often, but rousable, 3:asleep and not rousable).
Ventilatory frequency, oxygen saturation, arterial pressure, heart rate, nausea, vomiting and itching (yes:1/no:2) were measured at the same intervals as pain intensity. During the assessment, nurses also recorded the lowest oxygen saturation. Patients were given supplementary oxygen 2 litre min 91 if oxygen saturation was less than 90%. Postoperative blood loss was determined by measuring the contents of the suction bottles at the beginning and end of the study. Blood loss was replaced with infusions of Ringer's acetate and hydroxy ethyl starch. Packed red cells were given if needed to maintain a haemoglobin concentration greater than 100 g litre 91 .
The sample size was estimated to demonstrate with 90% power and at the 5% significance level 11 a difference of 30% in fentanyl consumption. The chisquare test was used to study the homogeneity of the groups in terms of sex, ASA classification and incidence of adverse effects. Analysis of variance with repeated measures was used for VAS scores. One-way analysis of variance was used for the rest of the variables and Scheffe's test to locate the differences. The homogeneity of variances was tested with Levene's test. The level of statistical significance was set as P:0.05.
Results
All 85 patients completed the 16-h study: 28 patients in the diclofenac group, 29 in the ketoprofen group and 28 in the ketorolac group. Patients who received diclofenac were significantly younger than those who received ketoprofen (P:0.02), while the difference between the diclofenac and ketorolac groups was not significant. There were no differences in sex, weight, ASA class, duration of operation, perioperative blood loss, postoperative drainage volume or duration of spinal anaesthesia between the groups (table 1) .
There was no significant difference in mean total consumption of PCA-administered fentanyl between the three groups during the 16-h study: 890 (SD 400) g in the ketorolac group, 920 (550) g in the diclofenac group and 850 (350) g in the ketoprofen group. The mean number of unsuccessful attempts from the PCA pump were 6.1 (range 0-41) in the ketorolac group, 5.0 (0-48) in the diclofenac group and 6.3 (0-49) in the ketoprofen group. Eight patients in the ketorolac group, 12 in the diclofenac group and seven in the ketoprofen group had no unsuccessful attempts. The range of unsuccessful attempts was too large to permit application of statistical methods. There were no differences between the groups in mean fentanyl consumption during the 5-6-h observation periods (table 2) .
Median VAS scores were low over the entire study and there was no significant difference between groups ( fig. 1 ).
There were no significant differences between groups in level of sedation, ventilatory frequency, heart rate, arterial pressure or oxygen saturation. Seven patients in the diclofenac group, 10 in the ketoprofen group and 12 in the ketorolac group required supplementary oxygen. Median oxygen saturations were 95-97% in all groups during the study.
The incidence of adverse effects is presented in table 3. Four patients in the diclofenac group and three in the ketoprofen group complained of pain or discomfort at the injection site compared with only one patient in the ketorolac group. However, there were no significant differences between groups. 
Discussion
We found that ketorolac wan equally efficacious as diclofenac and ketoprofen for the treatment of postoperative pain after hip replacement surgery. There were no significant differences between groups in mean total consumption of fentanyl during the 16-h study or in mean fentanyl consumption when measured in 5-6-h periods. Median VAS scores were low in all groups with no significant differences between groups. Adverse effects were minor, mostly nausea and vomiting, and were similar in the three groups.
The doses of anti-inflammatory drugs used in this study were based on the recommended maximal daily doses provided by the manufacturers. We considered the use of a placebo group to be unnecessary as the opioid-sparing effect of diclofenac and ketoprofen compared with placebo after similar surgery in similar patients had been demonstrated in previous studies from our departments. 1 2 In our ketoprofen study we compared the analgesic efficacy of i.v. ketoprofen 100 mg/12 h, 200 mg/12h and 300 mg/12h with a placebo group after total hip or knee replacement. 2 Total consumption of fentanyl during the study, used as rescue analgesia delivered by PCA, was significantly lower in all ketoprofen groups compared with placebo. Laitinen and Nuutinen compared i.v. diclofenac 150 mg/16 h with placebo after total hip replacement and in this study the diclofenac group showed a significant reduction in the amount of fentanyl administered during the 16-h study compared with the placebo group. 1 NSAID have potential side effects on platelet and renal function. There is always a risk of major haemorrhage, hypovolaemia and thereby renal underperfusion after hip replacement surgery. Administration of NSAID in the hypovolaemic situation may lead to severe renal failure, especially in older age groups. The short-term use of NSAID for surgical patients does not seem to induce irreversible renal failure, however, prospective controlled studies with large populations are required to study the incidence of renal side effects after administration of NSAID. NSAID inhibit platelet aggregation as long as they remain in the blood stream. 12 There have been controversial results regarding postoperative bleeding with parenteral ketorolac. 13 14 Strom and co-workers reported a low risk of operative site bleeding with ketorolac, 13 Gallagher, Blauth and Fornadley demonstrated an approximately five-fold increase in postoperative haemorrhage in patients who had received ketorolac in the perioperative period for tonsillectomy and adenoidectomy. 14 on platelet function in 10 healthy volunteers. 15 The drugs were administered on three different occasions, at more than 1-week intervals, in a randomized, double-blind, crossover study. Ketoprofen, ketorolac and diclofenac caused reversible platelet dysfunction. Diclofenac had the mildest effect, while platelet dysfunction was still seen 24 h after administration of ketorolac. In our study, we measured drainage volumes from the operation site during the study and there was no clinical or significant difference between groups.
In our study, all anti-inflammatory drugs were administered i.v. when spinal anaesthesia began to wear off at the operation site. Median VAS scores were the same (1.0) in all groups at the beginning of the study. The low VAS scores were probably a result of the use of the PCA device. However, there were patients in every group who had periodic short-term demands which were not covered by the PCA settings. All patients using a PCA device suffer a short period of inadequately relieved pain. With PCA, patients first have pain and then press the button, and there is a delay between administration of an analgesic and its action. However, the amount of analgesic delivered via the PCA device is an objective method for assessment of the efficacy of postoperative pain therapy.
Morrow, Bunting and Milligan compared the analgesic efficacy and side effects of ketorolac with diclofenac after day-case arthroscopy of the knee joint. 9 They administered a single deep i.m. injection of either ketorolac 30 mg or diclofenac 75 mg. Ketorolac provided better postoperative analgesia compared with diclofenac, was associated with a low incidence of pain at the injection site and the authors suggested that the superiority of ketorolac was underestimated. Morley-Forster, Newton and Cook compared i.m. ketorolac, rectal indomethacin and a placebo in healthy women undergoing gynaecological or breast surgery as outpatients. 16 The NSAIDtreated groups had less pain and required less fentanyl than the placebo group, but there were no differences between the two NSAID. Rorarius and co-workers compared the effect of constant infusion of diclofenac at a rate of 150 mg/24 h and ketoprofen 200 mg/24 h for the treatment of postoperative pain after elective Caesarean section and found these doses to be of similar efficacy. 17 In summary, we have found that ketorolac was as efficacious as diclofenac and ketoprofen in the treatment of postoperative pain after hip replacement surgery. 
